The present investigation elucidates a simple hydrothermal method for preparing nanostructured bismuth oxide (Bi2O3) and carbon quantum dot (CQD) composite using spoiled (denatured) milk-derived CQDs. The formation of the CQD–Bi2O3 composite was confirmed by UV–vis absorption, steady-state emission, and time-resolved fluorescence spectroscopy studies. The crystal structure and chemical composition of the composite were examined by X-ray diffraction, Fourier transform infrared spectroscopy, Raman spectroscopy, and thermogravimetric analysis. The surface morphology and the particle size distribution of the CQD–Bi2O3 were examined using field emission scanning electron microscope and high-resolution transmission electron microscope observations. As an anode material in lithium-ion battery, the CQD–Bi2O3 composite exhibited good electrochemical activity and delivered a discharge capacity as high as 1500 mA h g–1 at 0.2C rate. The supercapacitor properties of the CQD–Bi2O3 composite electrode revealed good reversibility and a high specific capacity of 343 C g–1 at 0.5 A g–1 in 3 M KOH. The asymmetric device constructed using the CQD–Bi2O3 and reduced graphene oxide delivered a maximum energy density of 88 Wh kg–1 at a power density of 2799 W kg–1, while the power density reached a highest value of 8400 W kg–1 at the energy density of 32 Wh kg–1. The practical viability of the fabricated device is demonstrated by glowing light-emitting diodes. It is inferred that the presence of conductive carbon network has significantly increased the conductivity of the oxide matrix, thereby reducing the interfacial resistance that resulted in excellent electrochemical performances.
A comprehensive review on the properties and versatile applications of fluorescent carbon dots in detecting nucleic acids, imaging nucleoli, and delivering genes.
Cationic carbon dots synthesized from p-phenylenediamine were employed to trigger the aggregation and dispersion of gold nanoparticles for the colorimetric detection of nucleic acids.
The widespread adoption and commercialization of lateral flow assays (LFAs) for clinical diagnosis have been hindered by limitations in sensitivity, specificity, and the absence of quantitative data. To address these challenges, we developed aptamer-architectured gold nanoparticles as nanozymes that catalytically convert para-phenylenediamine (PPD) into Bandrowski's base (BB), thereby amplifying signal strength and sensitivity. The physiochemical properties of the nanozymes were characterized and their specific binding efficiency was demonstrated using experimental studies. The nanozymes and PPD-based LFA test strips were evaluated for the detection of the COVID-19 spike protein in both test and clinical samples. Notably, we achieved a significant visual detection limit of 168 pg mL−1, with a signal quality enhancement of over 20-fold within 15-minute timeframe. Moreover, we rigorously tested 25 clinical samples to assess the transformative potential of the product, demonstrating a semi-quantitative analysis efficiency exceeding 90%. This performance outstripped commercially available LFA kits (87.5%). Notably, the colorimetric system exhibited an R2 value of 0.9989, a critical factor for clinical testing and industry integration. The incorporation of nanozymes and PPD in LFAs offers a cost-effective solution with significantly improved sensitivity, enabling the detection of ultra-low concentrations (picograms) of spike protein. By addressing key challenges in LFA-based diagnostics, the current technique underscores the potential of this transformative biomedical sensor for industry integration. It also highlights its suitability for commercialization, positioning it as a universal platform for diagnostic applications.